SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 84 filers reported holding SYNAGEVA BIOPHARMA CORP in Q4 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,555,000 | -67.5% | 15,957 | -69.1% | 0.00% | -66.7% |
| Q4 2014 | $4,791,000 | +121.5% | 51,640 | +64.1% | 0.00% | +200.0% |
| Q3 2014 | $2,163,000 | +117.0% | 31,461 | +230.7% | 0.00% | 0.0% |
| Q2 2014 | $997,000 | -71.4% | 9,514 | -77.5% | 0.00% | -50.0% |
| Q1 2014 | $3,490,000 | +53.5% | 42,275 | +20.3% | 0.00% | 0.0% |
| Q4 2013 | $2,274,000 | -15.8% | 35,153 | -17.6% | 0.00% | 0.0% |
| Q3 2013 | $2,700,000 | – | 42,647 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 11,660,432 | $1,137,242,000 | 9.46% |
| BB BIOTECH AG | 1,025,476 | $100,015,000 | 2.98% |
| EMORY UNIVERSITY | 9,854 | $961,000 | 1.82% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,245,542 | $316,538,000 | 1.72% |
| New Leaf Venture Partners, L.L.C. | 24,379 | $2,378,000 | 1.61% |
| Alpha Wave Global, LP | 304,000 | $29,649,000 | 1.46% |
| Opus Point Partners Management, LLC | 17,700 | $1,726,000 | 1.45% |
| SECTORAL ASSET MANAGEMENT INC | 365,684 | $35,665,000 | 1.35% |
| Pier Capital, LLC | 61,028 | $5,952,000 | 0.90% |
| Tekla Capital Management LLC | 198,689 | $19,378,000 | 0.77% |